CW+, the charity for Chelsea and Westminster Hospital NHS Foundation Trust, has announced a new partnership with Drayson Technologies to launch the first pilot of wireless environmental sensors in the intensive care units at Chelsea and Westminster Hospital.
This latest project, coordinated by Dr. Lawrence Petalidis, Head of Innovation and Impact at CW+, in partnership with Drayson Technologies, will pilot Drayson’s wireless, temperature and carbon monoxide sensors in both the adult and neonatal intensive care units. These sensors will allow for near real-time monitoring of room temperature and carbon monoxide concentrations, a metric of air quality.
The pilot forms part of CW+’s Critical Care Campaign to raise £10 million to significantly expand and redevelop both the adult and neonatal intensive care units at Chelsea and Westminster Hospital. This campaign will enable the hospital to treat 700 more critically ill adults and babies every year in state-of-the-art facilities with a leading patient-centered design, providing the best environment, facilities and technologies for patients and their families. Drayson Technologies’ environmental sensors will feature throughout these new units enabling staff to monitor the environment. The pilot forms the first part of CW+’s plans to create a ‘sensor rich environment’ that is anticipated to have a significant impact on critically ill patients’ wellbeing and their recovery.
Miss Zoe Penn, Medical Director for Chelsea and Westminster Hospital NHS Foundation Trust said: “We are delighted to be partnering with Drayson Technologies to pilot this truly innovative technology in our intensive care units. Together with our charity, we want to create the best possible environment for healing and being able to monitor the environmental conditions in near real-time will be crucial in achieving this.”
Chris Chaney, CEO of CW+ added: “We are excited to be part of this global healthcare first. We are very proud to be implementing digital healthcare innovations at our hospitals to improve patient experience and outcomes and look forward to working in partnership with Drayson Technologies on this groundbreaking programme.”
Lord Drayson, Chairman and CEO of Drayson Technologies, said: “We are especially pleased to support the CW+ Critical Care Campaign with this innovative pilot to help ensure the best possible environment for critically ill patients and their families at Chelsea and Westminster Hospital.”
